Search

everythinglearnresearchcommunity

for

Search:↓

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

IMSG nanoparticles improve vaccine delivery and immune response through hair follicles.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Changes to the Foxp3 protein affect how well regulatory T cells can control the immune system, which could help treat immune diseases and cancer.

Testosterone can both promote hair growth and cause baldness by affecting hair growth signals.

Langerhans cells and melanocytes migrate to the skin and hair follicles during early human development.

Symmetrical Acrokeratoderma (SAK) may be a unique skin condition in China, lacking specific treatment and needing long-term monitoring.

Convalescent Plasma Therapy may help treat COVID-19 Long-Hauler symptoms.

Mercury allergy linked to specific genes may contribute to burning mouth syndrome, and silicon might play a role in maintaining healthy hair.

The secretome from mesenchymal stem cells is a promising treatment that may repair tissue and avoid side effects of stem cell transplantation.

A group has developed therapies that show promise for treating cancer and various other conditions.

Rhodococcus equi causes severe pneumonia in young foals, and effective vaccines are needed due to foals' weak immune responses.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.

Oral vitamin D treatment can help some children with alopecia areata who have vitamin D deficiency.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Melatonin directly affects mouse hair follicles and may influence hair growth.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

MJ04, a new compound, effectively promotes hair growth and is a potential topical treatment for hair loss.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

The new gel combining calcipotriene and betamethasone is effective and safe for treating scalp psoriasis.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

The document concludes that the immune-inhibitory environment of the hair follicle may prevent melanoma development.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

UVB exposure in human skin causes macrophages to produce more IL-10 and less IL-12, leading to immunosuppression.